AA
LLY icon

ACT Advisors’s Eli Lilly LLY Stock Holding History

ACT Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$321K Buy
349
+23
+7% +$23.3K 0.14% 52
2025
Q4 		$351K Buy
326
+40
+14% +$38.2K 0.14% 46
2025
Q3 		$218K Sell
286
-38
-12% -$28.3K 0.09% 58
2025
Q2 		$253K Buy
324
+14
+5% +$10.9K 0.12% 47
2025
Q1 		$256K Sell
310
-8
-3% -$6.66K 0.14% 43
2024
Q4 		$246K Buy
318
+40
+14% +$33.1K 0.13% 42
2024
Q3 		$246K Buy
278
+14
+5% +$12.6K 0.12% 40
2024
Q2 		$239K Buy
+264
New +$211K 0.12% 39

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACT Advisors's LLY Position: Q1 2026 in Review

ACT Advisors increased its Eli Lilly (LLY) stake by 7.1% in Q1 2026, buying an estimated $23.3K and bringing the position to 349 shares worth $321K. The position accounts for 0.14% of the portfolio, ranked #52.

ACT Advisors first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. The position peaked at $351K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • ACT Advisors held 349 shares of Eli Lilly worth $321K as of Q1 2026.
  • ACT Advisors bought 23 Eli Lilly shares in Q1 2026, an estimated $23.3K.
  • Eli Lilly made up 0.14% of ACT Advisors's portfolio in Q1 2026, its #52 holding.
  • ACT Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
  • ACT Advisors's Eli Lilly position peaked at $351K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on ACT Advisors's 13F filing for Q1 2026, filed 14 Apr 2026.